Brussels, 15/09/2006 (Agence Europe) - It is extremely rare for a report to be defeated at the committee stage in the European Parliament. That, however, is what happened on 14 September to the report by Slovakian Christian Democrat MEP Miroslav Mikolasik on innovative therapies, defeated by 31 votes to 26, with 5 abstentions. At issue was the scope of the regulation introducing a centralised procedure (through the European Medicines Agency in London) for the authorisation of medicines...